For two centuries, industry ran on what we could dig up and burn. That era is ending. The next one runs on biology. Microorganisms, enzymes, and fermentation can already produce the food, chemicals, materials, and fuels that once depended on fossil resources. What started as a niche climate solution is becoming a foundational layer of the economy. Governments are building national strategies around it, and capital is following. But in all the excitement about new molecules and clever microbes, most people are looking in the wrong place.
The value is already in your building
Every food processor, distillery, brewery, and dairy produces side streams. Spent grain. Pot ale. Whey. Okara. Peelings, pulps, and process water. Most of it leaves the site as low-value animal feed, goes to biogas, or costs money to dispose of. Yet these streams are still packed with protein, sugars, fibre, and nutrients. They aren’t waste. They are raw material that hasn’t found its best use yet.
This is where fungi earn their place. Fungal fermentation can take a byproduct that nobody wants and upgrade it into something people do want: a protein-rich food ingredient, a functional material, a feedstock for the next process. Pair that with integrated biorefinery thinking, and a single stream can feed several value chains at once.
As waste volumes keep rising, so does the opportunity. And every operator facing tighter discharge limits and rising disposal costs is sitting on a decision: keep paying to get rid of it, or start getting paid for it.
The science isn’t the problem. Scale is.
Here is the uncomfortable truth about biomanufacturing: breakthroughs don’t build industries. Plenty of brilliant lab results never leave the lab. What separates the winners is whether they can produce economically at commercial scale. That means knowing what’s actually in your stream and how much of it you have. It means testing the techno-economics honestly before anyone pours concrete. It means a credible path from pilot to first plant, and the right partners at each step. Most companies don’t fail because the biology doesn’t work. They fail because they skipped straight to the big build without doing the groundwork.
Think IKEA, not cathedral
The old model of the biorefinery was the cathedral: huge, bespoke, decades to build, and only for the biggest players. I think that model is about to break. The future looks more like IKEA: modular components, configured to the stream, deployed in stages. Start small, prove the economics in a container-scale pilot, then scale what works. Automation removes the need for a specialist on every site. Lower cost and lower friction open the door to operators who were never in the market before. That is how bio-refineries become a new asset class rather than a one-off engineering project.
Where to start
You don’t start with a plant. You start with a map. Before anyone talks about investment, you need to understand what’s in your stream, what it could become, and what it’s worth. That’s the purpose of a ValorMap: a clear, low-risk diagnostic of where the hidden value sits and which routes are worth pursuing. The next industrial era will be built on biology. The question for every operator is simple: will your side streams stay a cost, or become your next revenue line?
Check out our valormapping platform at https://www.niskusbiotec.com
